Bilirubin index: a new standard for intervention?

Area of Science:

• Neonatal Medicine
• Pediatric Neurology
• Biochemistry

Background:

• Current neonatal jaundice management aims to keep bilirubin levels below 20 mg/dL.
• This threshold does not prevent kernicterus, lower IQs, or neurological abnormalities.
• Factors like protein binding, acidosis, hypoxia, and hemolytic disease influence bilirubin toxicity.

Purpose of the Study:

• To review factors contributing to bilirubin encephalopathy.
• To propose a new metric, the 'bilirubin index', for evaluating neonatal bilirubin levels.

Main Methods:

• Review of previously published studies on bilirubin toxicity.
• Identification of free bilirubin concentration and time as key variables.
• Proposal of the 'bilirubin index' as the area under the bilirubin vs. time curve.

Main Results:

• Established factors (hypoxia, acidosis, etc.) contribute to bilirubin encephalopathy.
• Free bilirubin concentration and time are critical for bilirubin flux.
• The proposed 'bilirubin index' integrates bilirubin levels over time.

Conclusions:

• The 'bilirubin index' offers a novel approach to assessing neonatal jaundice risk.
• Future research should focus on healthy term infants to correlate the index with neurological outcomes.
• This approach may help identify a more accurate 'threshold of toxicity' for intervention.